Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand

BACKGROUND: Chemoradiotherapy (CRT) with high cumulative doses (CDs) of cisplatin has been considered the standard of care for non-metastatic nasopharyngeal carcinoma (NPC). However, given most patients’ inability to tolerate high CDs due to cisplatin-related toxicities, the optimal CD of cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngamphaiboon, Nuttapong, Dechaphunkul, Arunee, Setakornnukul, Jiraporn, Dechaphunkul, Tanadech, Jiratrachu, Rungarun, Suktitipat, Bhoom, Jiarpinitnun, Chuleeporn, Pattaranutaporn, Poompis, Danchaivijitr, Pongwut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271552/
https://www.ncbi.nlm.nih.gov/pubmed/32493288
http://dx.doi.org/10.1186/s12885-020-07024-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271552/
https://www.ncbi.nlm.nih.gov/pubmed/32493288
http://dx.doi.org/10.1186/s12885-020-07024-8

Ejemplares similares